KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Change in Accured Expenses (2016 - 2025)

LifeMD's Change in Accured Expenses history spans 14 years, with the latest figure at -$5.1 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 260.43% year-over-year to -$5.1 million; the TTM value through Dec 2025 reached -$5.8 million, down 153.77%, while the annual FY2025 figure was -$5.8 million, 153.77% down from the prior year.
  • Change in Accured Expenses reached -$5.1 million in Q4 2025 per LFMD's latest filing, down from $4.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $6.2 million in Q3 2023 to a low of -$5.1 million in Q4 2025.
  • Average Change in Accured Expenses over 5 years is $933122.6, with a median of $771146.0 recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: skyrocketed 4200.86% in 2023, then crashed 1606.02% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $771146.0 in 2021, then surged by 83.49% to $1.4 million in 2022, then plummeted by 165.89% to -$932374.0 in 2023, then soared by 437.66% to $3.1 million in 2024, then crashed by 260.43% to -$5.1 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Change in Accured Expenses are -$5.1 million (Q4 2025), $4.5 million (Q3 2025), and -$3.0 million (Q2 2025).